CSP 465A - Non-traditional cardiovascular risk factors and atherosclerosis in type 2 diabetes.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antihyperglycaemics; Glimepiride; Insulin; Metformin; Rosiglitazone
- Indications Cardiovascular disorders; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 27 Jun 2014 Biomarkers information updated
- 29 Sep 2009 Actual initiation date (1 Jun 2007) added as reported by ClinicalTrials.gov
- 29 Sep 2009 Actual end date (1 May 2008) added as reported by ClinicalTrials.gov